A multi-organ disease that flares in cycles
Quick answer
Lupus is an autoimmune disease that can affect skin, joints, kidneys and blood. Mainstay therapy is immunomodulators and steroids scaled to severity. MSC research focuses on patients refractory to standard treatment, aiming to expand regulatory immune cells and calm inflammation.
The greatest concern in lupus is kidney involvement (lupus nephritis), the main driver of long-term renal loss. Urinalysis and kidney function need regular checks even when outward symptoms are quiet.
MSCs suppress overactive T and B cells and expand regulatory T cells, so some studies report falling anti-dsDNA antibodies and reduced steroid dose in selected patients — though long-term data remain limited.
The safe rule is that lupus patients must not taper their own medication after cell therapy. Steroid reduction has to be gradual and physician-led, since abrupt withdrawal triggers both flares and adrenal insufficiency.
There is no cure yet; the goal is remission and preventing organ damage.
A physician must decide; severe flares usually need standard therapy to gain control first.
Last updated: 2026-08-28 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categoriesRelated topics: Joints & immunity